Neoplasm Recurrence, Local
"Neoplasm Recurrence, Local" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site.
| Descriptor ID |
D009364
|
| MeSH Number(s) |
C04.697.655 C23.550.727.655
|
| Concept/Terms |
Neoplasm Recurrence, Local- Neoplasm Recurrence, Local
- Local Neoplasm Recurrences
- Locoregional Neoplasm Recurrence
- Recurrences, Local Neoplasm
- Neoplasm Recurrences, Local
- Recurrence, Local Neoplasm
- Recurrence, Locoregional Neoplasm
- Local Neoplasm Recurrence
- Neoplasm Recurrence, Locoregional
- Locoregional Neoplasm Recurrences
- Neoplasm Recurrences, Locoregional
- Recurrences, Locoregional Neoplasm
|
Below are MeSH descriptors whose meaning is more general than "Neoplasm Recurrence, Local".
Below are MeSH descriptors whose meaning is more specific than "Neoplasm Recurrence, Local".
This graph shows the total number of publications written about "Neoplasm Recurrence, Local" by people in this website by year, and whether "Neoplasm Recurrence, Local" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 3 | 6 | 9 |
| 1996 | 7 | 9 | 16 |
| 1997 | 4 | 8 | 12 |
| 1998 | 0 | 7 | 7 |
| 1999 | 6 | 4 | 10 |
| 2000 | 5 | 13 | 18 |
| 2001 | 3 | 10 | 13 |
| 2002 | 4 | 4 | 8 |
| 2003 | 9 | 10 | 19 |
| 2004 | 10 | 11 | 21 |
| 2005 | 6 | 14 | 20 |
| 2006 | 17 | 11 | 28 |
| 2007 | 13 | 14 | 27 |
| 2008 | 8 | 16 | 24 |
| 2009 | 14 | 12 | 26 |
| 2010 | 19 | 19 | 38 |
| 2011 | 14 | 7 | 21 |
| 2012 | 15 | 13 | 28 |
| 2013 | 20 | 19 | 39 |
| 2014 | 17 | 17 | 34 |
| 2015 | 21 | 16 | 37 |
| 2016 | 27 | 14 | 41 |
| 2017 | 24 | 8 | 32 |
| 2018 | 18 | 20 | 38 |
| 2019 | 30 | 23 | 53 |
| 2020 | 21 | 30 | 51 |
| 2021 | 21 | 22 | 43 |
| 2022 | 6 | 39 | 45 |
| 2023 | 1 | 39 | 40 |
| 2024 | 10 | 25 | 35 |
| 2025 | 5 | 3 | 8 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neoplasm Recurrence, Local" by people in Profiles.
-
Prevalence and Clinical Impact of BRAF p.V600E Mutation in Papillary Thyroid Carcinoma. Endocr Pathol. 2025 Apr 16; 36(1):13.
-
External validation of a model to predict recurrence-free and melanoma-specific survival for patients with melanoma after sentinel node biopsy. Br J Surg. 2025 Mar 28; 112(4).
-
Three-year analysis of adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3. Leukemia. 2025 May; 39(5):1058-1068.
-
Identification of Predictive Factors for the Development of In-Transit Metastasis in Patients with Melanoma. Ann Surg Oncol. 2025 May; 32(5):3203-3211.
-
Oncologic Outcomes with De-Escalation of Axillary Surgery After Neoadjuvant Chemotherapy for Breast Cancer: Results from > 1500 Patients on the I-SPY2 Clinical Trial. Ann Surg Oncol. 2025 May; 32(5):3278-3291.
-
Prognostic Value of Nevus-Associated Melanoma in Patients with Melanoma. Ann Surg Oncol. 2025 May; 32(5):3189-3197.
-
How to Predict Recurrence After Resection of Hepatocellular Carcinoma. Anticancer Res. 2025 Jan; 45(1):189-199.
-
Dermatofibrosarcoma Protuberans, Version 1.2025, NCCN Clinical Practice Guidelines In Oncology. J Natl Compr Canc Netw. 2025 Jan; 23(1).
-
Prognostic value of isolated tumor cells in sentinel lymph nodes in low risk endometrial cancer: results from an international multi-institutional study. Int J Gynecol Cancer. 2024 Feb; 34(2):179-187.
-
A non-comparative, randomized, phase II trial of atezolizumab or atezolizumab plus tiragolumab for programmed death-ligand 1-positive recurrent cervical cancer (SKYSCRAPER-04). Int J Gynecol Cancer. 2024 Aug; 34(8):1140-1148.